New marker for raised intracranial pressureSeptember 11, 2008Magnetic resonance imaging (MRI) measurements of the thickness of the optic nerve sheath are a good marker for raised intracranial pressure (ICP). New research published today in BioMed Central's open access journal Critical Care shows that a retro-bulbar optic nerve sheath diameter (ONSD) above 5.82mm predicts raised ICP in 90% of cases. The dural sheath surrounding the optic nerve communicates with the subarachnoid space and distends when ICP is elevated. Thomas Geeraerts, from Addenbrooke's Hospital, Cambridge, led a team who investigated whether MRI can be used to precisely measure the diameter of the optic nerve and its sheath. He said, "Raised ICP is frequent in conditions such as stroke, liver failure and meningitis. It is associated with increased mortality and poor neurological outcomes. As a result, the early detection and treatment of raised ICP is critical, but often challenging. Our MRI-based technique provides a useful, non-invasive solution". The early detection of raised ICP can be very difficult when invasive devices are not available. As the authors report, "Clinical signs of raised ICP such as headache, vomiting and drowsiness are not specific and are often difficult to interpret. In sedated patients, clinical signs frequently appear well after the internal damage has been done. Optic nerve sheath distension could be an early, reactive and sensitive sign of raised ICP".
The authors carried out a retrospective blinded analysis of brain MR images in a prospective cohort of 38 patients requiring ICP monitoring after traumatic brain injury and 36 healthy controls. Geeraerts said, "We found that ONSD measurement was able to provide a quantitative estimate of the likelihood of significant cranial hypertension". BioMed Central | |||||||||||||||||||||
|
Related Intracranial Pressure Current Events and Intracranial Pressure News Articles Widely-Used Treatment For Head Injuries Found To Be Harmful (pp 1291, 1321) The use of anti-inflammatory drugs to treat patients with severe head injuries-common practice worldwide for the past 30 years-is actually dangerous and associated with around a 20% increase in death within two weeks of hospital admission, conclude authors of an international study in this week's issue of THE LANCET. SEDATIVE LEADS TO CARDIAC FAILURE IN PATIENTS WITH HEAD INJURY (p117) The sedative propofol given to patients with head injury in intensive care units may lead to sudden cardiac failure, report researchers in this week’s issue of THE LANCET. Propofol is used as a sedative and as a general anaesthetic in surgery or procedures lasting less than one hour. In patients with head injury the drug is also aimed at lowering intracranial pressure. A link between children in intensive care receiving propofol and cardiac failure has previously been reported. Olaf Cremer and colleagues from the University Medical Centre, Utrecht, Netherlands, studied people aged 16-55 who were admitted to their neurosurgical intensive care unit between 1996-1999, and who were sedated More Intracranial Pressure Current Events and Intracranial Pressure News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||